IRGM and its mouse orthologue Irgm1 are dynamin-like proteins that regulate vesicular remodeling, intracellular microbial killing, and pathogen immunity. IRGM dysfunction is linked to inflammatory bowel disease (IBD), and while it is thought that defective intracellular killing of microbes underscores IBD susceptibility, studies have yet to address how IRGM/Irgm1 regulates immunity to microbes relevant to intestinal inflammation. Here we find that loss of Irgm1 confers marked susceptibility to Citrobacter rodentium, a noninvasive intestinal pathogen that models inflammatory responses to intestinal bacteria. Irgm1-deficient mice fail to control C. rodentium outgrowth in the intestine, leading to systemic pathogen spread and host mortality. Surprisingly, susceptibility due to loss of Irgm1 function was not linked to defective intracellular killing of C. rodentium or exaggerated inflammation, but was instead linked to failure to remodel specific colon lamina propria (C-LP) myeloid cells that expand in response to C. rodentium infection and are essential for C. rodentium immunity. Defective immune remodeling was most striking in C-LP monocytes, which were successfully recruited to the infected C-LP, but subsequently underwent apoptosis. Apoptotic susceptibility was induced by C. rodentium infection and was specific to this setting of pathogen infection, and was not apparent in other settings of intestinal inflammation. These studies reveal a novel role for Irgm1 in host defense and suggest that deficiencies in survival and remodeling of C-LP myeloid cells that control inflammatory intestinal bacteria may underpin IBD pathogenesis linked to IRGM dysfunction.
Introduction
The Immunity Related GTPases (IRG) are a family of large, dynamin-like GTPases that mediate immune and inflammatory responses to pathogenic challenges [1] [2] [3] . Their expression is stimulated by interferons and microbial products in both hematopoietic and non-hematopoietic cells, where they bind intracellular membranes and trigger diverse membrane remodeling and vesicle trafficking events. While much about these processes and the mechanisms by which they support immunity remains unclear, the importance of IRG functions are underscored by the existence of variants in the human IRGM gene that are associated with increased susceptibility to Mycobacterium tuberculosis [4, 5] , sepsis [6] , non-alcoholic fatty liver disease [7] , ankylosing spondylitis [8] , and Crohn's Disease (CD). CD is an inflammatory bowel disease thought to result from aberrant immune responses to intestinal microbes and CD-linked IRGM variants are linked with the overall incidence of CD [9, 10] but also with disease severity including ileal involvement [11] , fistulating disease [12] , and an increased need for surgery [13] . IRGM is the only IRG that is widely expressed in human cells and despite strong genetic evidence linking IRGM variants with CD, the means through which IRGM dysfunction confers CD susceptibility remains unknown.
Functional studies have demarcated a role for IRGM and its mouse orthologue, Irgm1, in regulating autophagy [14] [15] [16] [17] [18] and bacterial outgrowth during pathogenic infection. Irgm1-deficient mice are highly susceptible to intracellular bacteria including Listeria monocytogenes [19] , Salmonella typhimurium [20] , and Mycobacterium tuberculosis [21] . Susceptibility to these pathogens is linked to impaired abilities of Irgm1-deficient macrophages to kill intracellular bacteria [20, 21] , a functional deficiency that is also observed in IRGM-deficient human macrophages [15, 22] . Based on these studies, the prevailing model by which IRGM/Irgm1 controls immunity is by supporting mechanisms of intracellular microbial killing, including xenophagy. It is speculated that impaired xenophagy and microbial killing impacts immune responses to intestinal microbes relevant to CD. However, this model rests largely on in vitro studies employing cultured macrophages and little information exists concerning how IRGM/Irgm1 regulates macrophages and other immune cells in vivo.
Given the evidence linking IRGM/Irgm1 to both bacterial immunity and aberrant immunity in CD [17, 23] , it is surprising that no study has addressed how IRGM/Irgm1 regulates the functions of intestine-resident immune cells, or host immunity to intestinal pathogens. Moreover, with the focus of previous work on invasive, intracellular bacteria, little is known about IRGM/Irgm1's potential roles in promoting resistance to extracellular bacteria, by far the most abundant type of microbe in the intestine and key players in intestinal inflammation. A model organism in this class is Citrobacter rodentium, a Gram-negative, enteric pathogen of mice that induces intestinal inflammation sharing several histologic features with IBD [24, 25] . C. rodentium is noninvasive, and its infection resembles human infection with attaching and effacing E. coli [26] , clinically important microbes that cause diarrhea and gastrointestinal inflammation. Numerous studies have shown that C. rodentium infection is typically self-resolving, due to robust responses of both innate and adaptive immune cells [24, 25] .
Here we find that Irgm1 plays an important role in protective immunity to C. rodentium, but one that is distinct from its role in xenophagy and intracellular killing.
Results

Irgm1 function is required for C. rodentium immunity
We inoculated mice that have a global knockout of Irgm1 (Irgm1 -/-mice) [19] with C. rodentium intragastrically, and followed the course of infection over three weeks. While the vast majority of wild-type (WT) mice survived C. rodentium infection, ~40% of Irgm1 -/-mice died between 12 and 20 days post-infection (Fig 1a) . During that period, Irgm1 -/-mice also manifested marked weight loss that was not apparent in the control mice (Fig 1b) . To determine if Irgm1 function controlled C. rodentium outgrowth in the intestine, we quantified the abundance of C. rodentium in stool at day 7, 14 and 21 post-infection. Surprisingly, at day 7 the bacterial load was not significantly different between WT and Irgm1 -/-mice (Fig 1c) . However, while WT mice restricted pathogen outgrowth and sharply reduced bacterial load within 14 days post infection, C. rodentium continued to expand in the intestines of Irgm1 -/-mice, resulting in a bacterial burden 20-30-fold higher than that of WT mice. By day 21 many Irgm1 -/-mice had succumbed to the infection, and those that survived still had detectable levels of bacteria in stool. Long-term persistence of C. rodentium in Irgm1 -/-mice was in marked contrast to WT, in which no bacteria were detected at late timepoints. Taken together, these results suggest that Irgm1 function was required for immunity to C. rodentium and to restrict pathogen outgrowth in the intestine.
Given these results, we assessed whether failure to control C. rodentium in the intestine of Irgm1 -/-mice allowed bacteria to spread systemically. C. rodentium is non-invasive and its systemic spread is both rare and limited to hosts with significant defects in intestinal barrier function (e.g. [27, 28] ). Consistent with this model, we detected no C. rodentium in the spleens of infected WT mice (Fig 1d) . By contrast, several thousand live colony forming units of C. rodentium were detected in the spleens of Irgm1 -/-mice, and this abundance peaked at day 14 post-infection, a timepoint where exaggerated weight loss and mortality of Irgm1 -/-mice became evident. These data suggest that Irgm1 function is required to restrict pathogen expansion in the intestine, as well as its systemic spread.
Dysfunctional C. rodentium immunity in Irgm1-deficient mice is not linked to exaggerated intestinal inflammation C. rodentium reproducibly causes intestinal inflammation and is a standard model to study host dynamics in infectious colitis. Irgm1 -/-mice develop robust colitis upon treatment with dextran sodium sulfate (DSS colitis) [17] and given that C.
rodentium infected Irgm1 -/-mice poorly controlled pathogen outgrowth, displayed heightened mortality and exaggerated weight loss, we hypothesized that infected Irgm1 -/-mice would also display exaggerated intestinal inflammation and colitis. We focused on day 14 post infection, as it was the point at which Irgm1 -/-mice exhibited clear signs of mortality and weight loss (Fig 1) . In contrast to our prediction, inflammatory scores were not significantly different between Irgm1 -/-and WT mice (Fig 2a-d) . We performed extensive histologic analysis for edema, epithelial hyperplasia, epithelial integrity, and cellular infiltrate in both cecum and distal colon, the primary and secondary sites for C. rodentium replication. In the cecum, none of the 4 parameters analyzed nor the aggregate inflammation score were statistically different between Irgm1 -/-and WT mice (Fig 2a,b) . Only edema in distal colon showed a statistically significant increase in Irgm1 -/-mice, although this difference was modest and did not significantly impact the aggregate inflammation score (Fig 2c,d) . Pathology was scored in a blinded fashion by three independent individuals, with similar results (data not shown). As an additional measure for inflammation we quantified gene expression for TNFα in colon tissues. TNFα mRNA was upregulated in colon following infection, but levels in WT and Irgm1 -/-mice were very similar, even at time points when mortality and weight loss of Irgm1 -/-mice were readily apparent (Fig 2e) . Taken together, these data suggest that mechanisms underpinning defective C. rodentium immunity in Irgm1 -/-mice and pathogen outgrowth were not linked to the severity of intestinal inflammation.
To further investigate the inflammatory response against C. rodentium, we quantified expression of Reg3ɣ, an antimicrobial peptide produced by intestinal epithelial cells that suppresses C. rodentium outgrowth and is known to be expressed in an Irgm1-dependent fashion during DSS colitis [17, 29] . In response to C. rodentium infection Reg3ɣ was robustly expressed in colon tissue, and expression was actually elevated in Irgm1 -/-mice, perhaps due to exaggerated pathogen expansion in these mice (Fig 2f) . C. rodentium infected Irgm1 -/-mice also displayed robust and elevated gene expression of IL-22, an essential cytokine for host defense against C. rodentium and tissue repair in the intestine [30] (Fig   2g) . Taken together, these histologic and gene expression data suggest that Irgm1 -/-mice elicit an apparently normal tissue inflammatory and repair response to C. rodentium and that pathogen outgrowth, systemic spread, and mortality cannot be explained by "general susceptibility" of Irgm1 -/-mice to intestinal inflammation, or by deficiency in key host defense cytokines.
Loss of Irgm1 function compromises immune remodeling of monocyte/macrophage populations in response to C.
rodentium
Pathogens and other inflammatory stimuli induce Irgm1 expression in both immune and non-immune populations and there are thus multiple potential sources in which Irgm1 could be critical for host defense to C. rodentium. Since the cellular responses of intestinal epithelial cells to C. rodentium appeared to be independent of Irgm1, we hypothesized that mechanisms underpinning dysfunctional C. rodentium immunity in Irgm1 -/-mice were linked to hematopoietic cells. To test this we generated Irgm1 -/-hematopoietic chimeric mice by adoptively transferring Irgm1 -/-bone marrow into irradiated WT recipients. Irgm1 -/- WT hematopoietic chimera were highly susceptible to C. rodentium infection and manifested severe weight loss and early mortality, paralleling outcomes with Irgm1 -/-mice ( Fig S1) . Thus, Irgm1-deficiency in hematopoietic cells is sufficient for dysfunctional C. rodentium immunity.
Having identified hematopoietic cells as the source of C. rodentium susceptibility in Irgm1 -/-mice we investigated macrophages, since these are the most abundant phagocytes in the intestine, and multiple lines of evidence support Irgm1 as a critical regulator of macrophage-intrinsic mechanisms of pathogen defense [20, 21] . Using Irgm1 -/-bone marrow derived macrophages we tested whether Irgm1 was required for macrophages to uptake and kill intracellular C.
rodentium, and surprisingly found that these defense mechanisms were both robust and undiminished as compared to WT (Fig 3) . This outcome is in contrast to prior reports showing a requirement for Irgm1 for macrophage killing of Salmonella typhimurium [20] and Mycobacterium tuberculosis [21] . Fig S3) . C. rodentium infection is known to induce significant remodeling of monocytes/macrophages, and while these populations were indeed profoundly altered after infection, infection-induced remodeling was markedly distinct between Irgm1 -/-and WT mice (Fig 4a,b) . First, WT mice numerically expanded mature MHC-II hi macrophages 2-fold upon C. rodentium infection (Fig 4c) . By contrast, macrophage expansion did not occur in C. rodentium infected
Irgm1
-/-mice, suggesting that these mice were deficient in mechanisms that support remodeling and expansion of C-LP macrophages in response to C. rodentium. Because mature macrophages are not proliferative, failure to expand macrophages in infected Irgm1 -/-mice suggests underlying defects in C-LP macrophage precursors. Consistent with this hypothesis, infected Irgm1 -/-mice were markedly deficient in Ly6C + MHC-II + transitioning monocytes, a direct precursor of C-LP macrophages and a population known to be key for C. rodentium immunity (Fig 4d) [31, 34] . Thus, while the WT response to C. rodentium elicited >15-fold expansion of Ly6C + MHC-II + transitioning monocytes, this population underwent little to no expansion in Irgm1 -/-mice, and total numbers were numerically similar to that of uninfected controls (Fig 4d) . Failure to expand transitioning monocytes in Irgm1 -/-mice was not due to a deficiency in monocyte precursors, since these expanded 4-fold after infection and were actually increased in abundance as compared to WT (Fig   4e) . Exaggerated numbers of monocytes, yet deficiency in their progeny, suggest that in response to C. rodentium infection the developmental transition of monocytes into C-LP macrophages was an Irgm1-dependent process.
Failure to remodel monocyte/macrophage populations was not due to immunological "ignorance" to C. rodentium or general myeloid failure since neutrophil expansion, a hallmark of C. rodentium immunity, was robust and increased >150-fold over baseline in infected Irgm1 -/-mice (Fig 4f) . (Fig 4g) . DSS treated Irgm1 -/-mice did have a reduced number of macrophages, but unlike the WT response to C. rodentium, the number of macrophages in WT mice did not increase during DSS colitis, suggesting that the cause for macrophage decline in Irgm1 -/-mice in DSS colitis was distinct from mechanisms underpinning failure to expand macrophages for C. rodentium immunity. Taken together, these data highlight stimulus-specific immune remodeling in C-LP and suggest that Irgm1's function in monocyte/macrophage remodeling is context dependent, and especially important upon intestinal infection with C. rodentium.
Irgm1 function is required to support CD4 T cell IFN responses to C. rodentium infection
Despite marked deficiencies in monocyte/macrophage remodeling, all Irgm1 -/-mice survived to at least 10 days post infection, a time point at which adaptive immunity would be expected to play a role in host defense. Since monocyte/macrophage deficiencies are linked to deficiencies in C. rodentium-induced IFN-producing CD4 T cells (Th1) [34] , we hypothesized that these would be deficient in Irgm1 -/-mice. Indeed, expansion of Th1 cells following C.
rodentium infection was significantly impaired, reduced to just 30% that of WT (Fig 5a-c) . By contrast, numbers of IL-17-producing CD4 T cells (Th17) and Foxp3 + T regulatory cells were intact (Fig 5d and S4 Given the defects in IFN-producing CD4 T cells, we also analyzed dendritic cells (DCs), since these are required to activate naïve T cells and induce protective C. rodentium immunity [35] [36] [37] . There are three DC subsets in colon and all three were significantly reduced in C. rodentium infected Irgm1 -/-mice (Fig 5f-h rodentium outgrowth and systemic spread.
Myeloid cell deficits in C-LP of Irgm1-deficient mice is underscored by increased apoptotic cell death following C. rodentium infection
Given that Irgm1 -/-mice had defects in innate and adaptive immune responses to C. rodentium infection, we sought to identify the cell-intrinsic requirements for Irgm1 in myeloid or lymphoid cells. To do so, we generated mixed hematopoietic chimeric mice by reconstituting WT mice that expressed both CD45. Considering these results, we hypothesized that the decline of Irgm1-deficient myeloid cells in mixed hematopoietic chimera resulted from higher rates of cell death during C. rodentium infection. To address this question we used Irgm1 -/-mice, since all immune cell types were readily analyzed in these mice without the challenges imposed by low cell number and reduced competitiveness/fitness of Irgm1-deficient cells present in mixed chimera. We first analyzed cell death in monocytes and transitioning monocytes since these were the most robustly expanded populations during C. rodentium infection, and were populations in which Irgm1-deficiency had great impact on infection-induced remodeling (Fig 4) .
Indeed, the abundance of Annexin V + C-LP monocytes in C. rodentium infected Irgm1 -/-mice was on average >20 fold higher than that of WT, with Annexin V expressed by as many as 40% of all C-LP monocytes (Fig 7a,b) . By contrast, fewer than 1% of C-LP monocytes were Annexin V + in infected WT mice, supporting the conclusions that C. rodentium infection was not inherently an apoptosis-inducing condition, and also, that increased monocyte apoptosis in Irgm1 -/-mice reflected a genotype-intrinsic susceptibility phenotype. Importantly, this susceptibility phenotype was induced by C.
rodentium infection and was specific for monocytes within C-LP, since Annexin V expression was only marginally increased among bone marrow monocytes of C. rodentium infected mice, or among C-LP monocytes of uninfected mice (Fig S7) . Also, neither of these monocyte populations had an increase in Annexin V + 7AAD + cells, which were significantly increased among C-LP monocytes in C. rodentium infected Irgm1 -/-mice (Fig 7b) . To further delineate the requirements wherein Irgm1 function was key to prevent monocyte apoptosis within C-LP, we analyzed monocytes during DSS colitis. Following DSS treatment Annexin V expression on C-LP monocytes was similar between WT and Irgm1 -/-mice (Fig 7c,d ), indicating that Irgm1 was not required to support monocyte survival in the setting of DSS colitis.
Taken together, these studies suggest that C. rodentium infection is a unique stress in which Irgm1 has critical function to prevent dramatic rates of monocyte apoptosis.
Irgm1 function also prevented infection-induced apoptosis of C-LP Ly6C + MHCII + transitioning monocytes, populations that are directly derived from monocytes and are typically robustly expanded in response to C. rodentium (Fig 7e,f) .
Infected Irgm1 -/-mice were markedly deficient in Ly6C + MHCII + transitioning monocytes (Fig 4) and among the few Ly6C + MHCII + cells that were present, Annexin V expression was >3 fold higher that of WT mice (Fig 7f) . Similar to monocytes, the requirement for Irgm1 to prevent apoptosis of Ly6C + MHCII + transitioning monocytes was both specific to and induced by C. rodentium infection, since there was little to no difference in apoptosis of these cells in uninfected mice, or in DSS-treated mice (Fig 7g,h and Fig S8) . Infection-induced apoptosis of both monocytes and their Ly6C + MHCII + progeny in Irgm1 -/-mice provide a rational explanation for why Ly6C + MHCII + transitioning monocytes failed to expand in response to C. rodentium infection. Since monocytes/transitioning monocytes are precursors of C-LP macrophages, infection-induced apoptosis of these macrophage precursors is also likely to explain why Irgm1 was required to expand C-LP macrophages in response to C. rodentium infection. Consistent with this hypothesis the apoptotic susceptibility of macrophages, while increased at baseline, was not significantly enhanced by C. rodentium infection (Fig.   S9 ), suggesting that failure to expand C-LP macrophages for C. rodentium immunity was primarily due to marked deficiency in the total number and overall viability of C-LP macrophage precursors, factors which were highly Irgm1-dependent. Paralleling our findings on monocytes, C. rodentium infection-induced apoptosis was prominent in all subsets of C-LP DCs, and was specific to this setting since increased apoptosis was not evident in DSS colitis ( Current dogma presumes that the role for IRGM/Irgm1 in xenophagy is the primary function for the proteins in immunity, and it is certainly likely to be a pivotal component of antibacterial immunity in some contexts. However, the requirements for host defense are unique for each pathogen, and pathogen defense in the intestine is particularly unique, since an unbalanced immune response to pathogens, or to the resident microbiota, can lead to chronic intestinal inflammation. Here we show that Irgm1 is required for immunity to an intestinal pathogen, and delineate that this requirement depends on a novel function for Irgm1 to regulate survival of C-LP mononuclear phagocytes and to support infection-induced remodeling of C-LP immune populations specialized for immunity to the extracellular enteric bacterium C. rodentium.
At Th17 responses to C. rodentium [44] . Whatever the cause, it is clear that Th17 and Th1 responses have distinct requirements for Irgm1. Since monocytes/macrophages and DCs are both linked to Th1 immunity to C. rodentium, whether Irgm1 dysfunction in DCs alone, monocytes/macrophages alone, or the combined defects of both cell types underpins the failure to expand Th1 cells for C. rodentium immunity awaits further experiments with lineage-specific knockout mice once they are developed.
Our studies describe a novel function for Irgm1 to regulate apoptosis in multiple cell types, including monocytes and macrophages. Although previous studies concluded that Irgm1 deficiency had no negative impact on macrophage apoptosis [20] , our studies on macrophage apoptosis deviate from prior work in several ways. First, while most work on Irgm1 has been conducted on bone marrow macrophages tested in vitro, we investigated primary cells in their native tissue environment and in so doing, revealed a novel role for Irgm1 as a regulator of apoptosis in C-LP macrophages and their monocyte precursors. Second, we show that this function of Irgm1 is critical only in specific settings of stress, since
Irgm1 was required for immune cell survival during C. rodentium infection, but was dispensable in DSS colitis. This finding is particularly outstanding, since DSS colitis and C. rodentium infection trigger similar histological and immunological changes in the intestine, and both stimulate the remodeling and expansion of C-LP monocytes/transitioning monocytes. That the requirements for Irgm1 for cell survival are distinct in these two inflammatory settings highlights the unique cellular and molecular requirements that tailor C-LP immune responses and specialize them to confront different types of insults. The stimulus-specific requirements for Irgm1 also extend to intestinal epithelial cells, which require Irgm1 to express Reg3ɣ in DSS colitis [17] , yet during C. rodentium infection upregulate Reg3ɣ in an Irgm1-independent fashion. Potential explanations as to why Irgm1's function to prevent monocyte apoptosis is most critical during C. rodentium infection may be that pathogen-specific factors trigger apoptosis directly [45, 46] , or that these factors induce specific changes in C-LP monocytes/macrophages, which reasonably have distinct molecular requirements based on the nature of the stimulus. The specific mechanism through which lack of Irgm1 leads to apoptosis is currently unclear, but may relate to previous roles defined for Irgm1/IRGM in regulating mitochondrial dynamics and autophagy, both of which are heavily intertwined with apoptosis [47, 48] . This will be a key area in which to focus future research.
In summary, our results expand the paradigm for Irgm1/IRGM-mediated host defense by demonstrating a critical requirement for Irgm1/IRGM proteins to control the survival and remodeling of monocytes and macrophages that expand during enteric infection and defend against inflammatory bacteria. Failure to remodel and/or sustain immune cells which are specialized to manage such bacteria represent a novel mechanism that may underpin CD pathogenesis linked to IRGM dysfunction.
Materials and Methods
Mice. Irgm1 -/-mice have been described previously [2, 19] . They have been backcrossed to C57Bl/6NCr1 mice for 9 generations and were maintained by breeding Irgm1 +/-mice. The Irgm1 +/+ and Irgm1 -/-mice used in these experiments were littermates and were co-housed under specific pathogen free (SPF) conditions. All procedures were approved by the IACUC of the Durham VA and Duke University Medical Centers.
Citrobacter rodentium infection. Mice were infected by oral gavage with 0.1 ml of an overnight culture of Luria broth (LB) containing ∼2.5 × 10 8 colony-forming units of streptomycin-resistant C. rodentium (formerly C. freundii biotype 4280, strain DBS100). Mice were weighed daily and monitored for signs of illness or distress. Bacterial counts were determined in fresh catch fecal pellets or sterilely-excised spleens by homogenization in PBS, followed by plating of serial dilutions of the homogenate on LB/streptomycin plates, with colony counts assessed the following day.
Histopathological scoring. Cecum and distal colon tissue from day 10 of C. rodentium infected mice were fixed in formalin and paraffin sections were stained using hematoxylin and eosin. Blinded histological scores were assigned using a previously validated scale [49] . The tissue was assessed for: submucosal edema (0 = no change; 1 = mild; 2 = moderate; Reg3ɣ from Applied Biosystems (Mm00441127_m1).
Relative gene expression was determined using the comparative threshold cycle (Ct) method [51] . Briefly, fold change The cells were then incubated for various times in BMM medium supplemented with 6 g/mL gentamycin. To quantify bacterial levels, the cells were washed with DMEM three times, and then lysed with 0.2 % (v/v) triton X-100 in PBS.
Dilutions of the lysates were plated on LB plates, and colony forming units were counted. The assay was performed in triplicate for each condition.
Preparation of colonic lamina propria and immune cell phenotyping.
Colon lamina propria were processed as described [39] Briefly, colon was cut longitudinally and washed thoroughly to remove luminal contents. Colon was then cut into 0.3cm pieces and washed twice for 10 minutes in HBSS/10mM HEPES/0.035% NaHCO3/5mM EDTA/1.25% BSA/1mM DTT, followed by another 10 min wash in HBSS/10mM HEPES/0.035% NaHCO3/1.25%BSA. Tissue was transferred to C-tubes (Miltenyi) and digested using Liberase TM (Roche, 57.6 g/ml) in the presence of DNase I (Sigma-Aldrich, 8 U/ml). Tissues were incubated with agitation for 30 min at 37°C, then dissociated using the GentleMACS™ Dissociator (Miltenyi). The resulting cellular suspension was filtered through a 100m mesh (BD Falcon), centrifuged, and subjected to RBC lysis. After RBC lysis, cell suspension was filtered through a 40m mesh (BD Falcon). Buffer Set (eBioscience). Annexin V staining and analysis was performed using Annexin V binding buffer (Biolegend).
For intracellular cytokine staining, lamina propria cells were resuspended in complete RPMI and stimulated for 4h with PMA (50 ng/ml) and ionomycin (500 ng/ml) in the presence of BD Golgi plug (BD Biosciences), and then stained for intracellular cytokines using the Cytofix/Cytoperm kit (BD biosciences). Flow cytometry analysis of cells was performed on a BD Canto (BD Biosciences), and data further analyzed using FlowJo software.
Hematopoietic chimera.
To generate hematopoietic chimera, 10-week-old CD45.1 + WT mice were irradiated with two doses of 600 cGy (X-RAD 320), with 3h rest between doses. Irradiated mice were injected intravenously with 8x10 6 were quantified from co-housed Irgm1 +/+ and Irgm1 -/-littermates treated with DSS for six days. Mice given no DSS were analyzed in tandem. Each dot represents one mouse. Data in (c-f) were combined from two independent experiments using co-housed littermates for each experimental condition. Error bars represent mean ± SD. *p < 0.05, **p < 0.01, ****p < 0.0001, n.s., not significant (unpaired Student's t test). + DCs (h). Data were combined from three independent experiments using co-housed littermates for each experimental condition. Each dot represents one mouse. Error bars represent mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, n.s., not significant (unpaired Student's t test). 
Supplementary Figure 3.
Total cell number of C-LP MHC-II lo macrophages in uninfected or C. rodentium infected mice of the indicated genotype.
Data were combined from two independent experiments. Error bars represent mean ± SD. n.s., not significant (unpaired Student's t test)
Supplementary Figure 4.
Total cell number of C-LP Foxp3+ CD4 T cells in uninfected or C. rodentium infected mice of the indicated genotype.
Data were combined from two independent experiments. Error bars represent mean ± SD. *p < 0.05, n.s., not significant (unpaired Student's t test).
Supplementary Figure 5.
Distal colon from uninfected or C. rodentium infected mice described in (a-b) Mixed hematopoietic chimera described in Fig. 6 were infected with C. rodentium for 10 days and (a) C. rodentium infected mice described in Fig. 7 SD. *p < 0.05, **p < 0.01, ****p < 0.0001 (unpaired Student's t test). 
